文献速递心力衰竭与心肌病心律失常

心肌炎临床与影像诊断标准的预后意义

Prognostic Implications of Clinical and Imaging Diagnostic Criteria for Myocarditis.
PubMed 文献 · J Am Coll Cardiol · 2024-01-01

本研究在1557例疑似心肌炎并转诊心脏磁共振的患者中,比较了ESC临床疑似心肌炎标准、更新版Lake-Louise标准(LLC)、AHA可能急性心肌炎标准及专家共识急性/复杂心肌炎标准的预后价值。中位随访3.4年,161例(15.3%)发生复合终点事件。满足LLC者年化事件率最高(6.6%),不满足ESC标准者预后良好(年化事件率0.7%)。ESC标准与LLC是多变量分析中最强的独立预后预测因素。

要点

  • ESC标准诊断覆盖率高(89.3%),LLC仅覆盖28.5%。
  • 满足LLC者年化事件率最高(6.6%),不满足ESC标准者预后良好(0.7%)。
  • ESC标准与LLC对复合终点均有独立及增量预后价值。

核心结论

  • 在真实世界疑似心肌炎队列中,ESC标准诊断覆盖率远高于LLC,但两者均为独立且增量预后预测因素。
  • 临床与心脏磁共振(CMR) findings 在心肌炎诊断和风险分层中具有互补作用。

研究设计与样本

  • 多中心队列研究,纳入2个中心因临床怀疑心肌炎转诊心脏磁共振的患者。
  • 排除既往心肌病患者,最终分析1050例无其他诊断者(62.6%男性,年龄48.9±16.8岁)。
  • 比较ESC临床疑似心肌炎标准、LLC、AHA可能急性心肌炎(pAM)标准及专家共识急性心肌炎(AM)和复杂心肌炎(CM)标准与复合终点事件的关联。

主要发现

  • 938例(89.3%)满足ESC标准,299例(28.5%)满足LLC,356例(33.9%)满足pAM,216例(20.6%)满足AM,77例(7.3%)满足CM。
  • 中位随访3.4年,161例(15.3%)发生复合终点事件(心衰住院、复发性心肌炎、持续性室速或死亡)。
  • 满足LLC者年化事件率最高(6.6%),不满足ESC标准者年化事件率0.7%。
  • 调整临床特征后,ESC标准(HRadjusted 3.87;95%CI 1.22-12.2;P=0.021)和LLC(HRadjusted 2.53;95%CI 1.83-3.49;P<0.001)为最强多变量结局预测因素。

关键数值与推荐

  • ESC临床疑似心肌炎标准:938/1050例(89.3%)满足。
  • 更新版Lake-Louise标准(LLC):299/1050例(28.5%)满足。
  • AHA可能急性心肌炎(pAM)标准:356/1050例(33.9%)满足。
  • 专家共识急性心肌炎(AM)标准:216/1050例(20.6%)满足;复杂心肌炎(CM)标准:77/1050例(7.3%)满足。

临床怎么用

  • 对疑似心肌炎患者,可同时应用ESC临床标准和LLC进行诊断与风险分层。
  • 不满足ESC标准者短期预后良好,年化事件率仅0.7%。
  • 满足LLC者年化事件率最高(6.6%),需加强监测与管理。

局限性

  • 仅纳入转诊行心脏磁共振的患者,可能存在选择偏倚。
  • 排除了既往心肌病患者,结论不适用于该人群。
  • 观察性设计,残余混杂可能影响预后关联的因果解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The European Society of Cardiology (ESC), the American College of Cardiology, the American Heart Association, and expert consensus documents provide different diagnostic criteria for myocarditis. Their overlap and prognostic value have never been compared. OBJECTIVES: This study aims to assess and compare the predictive value of ESC criteria for clinically suspected myocarditis, updated Lake-Louise criteria (LLC), American Heart Association criteria for probable acute myocarditis (pAM), and expert consensus criteria for acute myocarditis (AM) and complicated myocarditis (CM). METHODS: Patients with a clinical suspicion of myocarditis referred for cardiac magnetic resonance were enrolled at 2 centers. Those with any prior cardiomyopathy were excluded. The association of composite outcome events (heart failure hospitalization, recurrent myocarditis, sustained ventricular tachycardia, or death) with ESC diagnostic criteria, LLC, pAM, AM, and CM were compared. RESULTS: Among 1,557 consecutive patients referred for cardiac magnetic resonance with possible myocarditis, 1,050 (62.6% male; 48.9 ± 16.8 years of age) were without an alternative diagnosis. Of those, 938 (89.3%) met ESC criteria for clinically suspected myocarditis, 299 (28.5%) LLC, and 356 (33.9%), 216 (20.6%), and 77 (7.3%) pAM, AM, and CM, respectively. Adverse events occurred in 161 patients (15.3%) during a median follow-up of 3.4 years. The highest annualized event rates (6.6%) were observed in patients meeting LLC, whereas negative ESC criteria indicated excellent prognosis (0.7% annualized event rate). Among all myocarditis definitions, ESC criteria and LLC were the strongest multivariable outcome predictors and had independent and incremental prognostic value (HRadjusted: 3.87; 95% CI: 1.22-12.2; P = 0.021, and HRadjusted: 2.53; 95% CI: 1.83-3.49; P < 0.001, respectively) when adjusted for clinical characteristics. CONCLUSIONS: In a real-world cohort of patients with possible myocarditis, diagnosis was reached in most patients using ESC criteria whereas only approximately one-quarter of patients reached a diagnosis with LLC. The independent prognostic value of ESC-criteria and LLC highlights the complementary role of clinical and CMR-based findings in the diagnosis and risk stratification of myocarditis.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Bernhard B, Marxer ME, Zurkirchen JC, et al. Prognostic Implications of Clinical and Imaging Diagnostic Criteria for Myocarditis. J Am Coll Cardiol. 2024. PMID: 39357935. doi:10.1016/j.jacc.2024.07.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。